Show simple item record

dc.date.accessioned2020-08-19T15:44:44Z
dc.date.available2020-08-19T15:44:44Z
dc.date.issued2020-08-19
dc.identifier.govdocPAHO/IMS/EIH/COVID-19/20-0016
dc.identifier.urihttps://iris.paho.org/handle/10665.2/52588
dc.description.abstractMore than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we examined 30 therapeutic options.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectPandemicsen_US
dc.subjectEvidence-Informed Policyen_US
dc.titleOngoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review, 11 August 2020en_US
dc.typeTechnical reportsen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.contributor.departmentEvidence and Intelligence for Action in Health (EIH)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO